Catalent Inc (CTLT)
55.48
-0.32
(-0.58%)
USD |
NYSE |
Apr 19, 16:00
55.27
-0.20
(-0.37%)
After-Hours: 18:59
Catalent Cash from Operations (TTM): 174.00M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 174.00M |
September 30, 2023 | 276.00M |
June 30, 2023 | 254.00M |
March 31, 2023 | 127.00M |
December 31, 2022 | 329.00M |
September 30, 2022 | 184.00M |
June 30, 2022 | 439.00M |
March 31, 2022 | 504.00M |
December 31, 2021 | 441.00M |
September 30, 2021 | 446.00M |
June 30, 2021 | 433.00M |
March 31, 2021 | 471.40M |
December 31, 2020 | 518.10M |
September 30, 2020 | 564.80M |
June 30, 2020 | 440.00M |
March 31, 2020 | 355.80M |
December 31, 2019 | 309.40M |
September 30, 2019 | 232.00M |
June 30, 2019 | 248.00M |
March 31, 2019 | 263.10M |
December 31, 2018 | 283.00M |
September 30, 2018 | 332.00M |
Date | Value |
---|---|
June 30, 2018 | 374.50M |
March 31, 2018 | 371.40M |
December 31, 2017 | 379.50M |
September 30, 2017 | 334.90M |
June 30, 2017 | 299.50M |
March 31, 2017 | 233.20M |
December 31, 2016 | 179.80M |
September 30, 2016 | 158.70M |
June 30, 2016 | 155.30M |
March 31, 2016 | 198.50M |
December 31, 2015 | 242.90M |
September 30, 2015 | 256.50M |
June 30, 2015 | 171.80M |
March 31, 2015 | 179.70M |
December 31, 2014 | 138.30M |
September 30, 2014 | 113.30M |
June 30, 2014 | 178.30M |
March 31, 2014 | 147.80M |
December 31, 2013 | 152.40M |
September 30, 2013 | 150.80M |
June 30, 2013 | 137.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
127.00M
Minimum
Mar 2023
564.80M
Maximum
Sep 2020
355.08M
Average
355.80M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Eli Lilly and Co | 4.240B |
Merck & Co Inc | 13.01B |
Elanco Animal Health Inc | 271.00M |
Moderna Inc | -3.118B |
Avrobio Inc | -63.19M |